Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Leprfa/fa Rats
Authors:
- Luis FontanaLuis Fontana
- Julio Plaza-DíazJulio Plaza-Díaz
- Paula Robles-BolívarPRPaula Robles-Bolívar
- Héctor Valente-GodínezHVHéctor Valente-Godínez
- María José Sáez-LaraMSMaría José Sáez-Lara
- Francisco Abadía-MolinaFAFrancisco Abadía-Molina
- Carolina Gómez-LlorenteCGCarolina Gómez-Llorente
- Ángel GilÁGÁngel Gil
- Ana I. Álvarez-MercadoAÁAna I. Álvarez-Mercado
Open Access
Abstract
Non-alcoholic fatty liver disease (NAFLD) has reached pandemic proportions worldwide. We have previously reported that the probiotic strains Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 exert anti-inflammatory effects in the intestine of Zucker-Leprfa/fa rats. In this work, we focused on their hepatic effects. M1 macrophages are related to inflammation and NAFLD pathogenesis, whereas M2 macrophages release anti-inflammatory mediators. We evaluated the effects of these 3 strains on macrophage polarization, inflammation and liver damage of Zucker-Leprfa/fa rats. The animals received either a placebo or 1010 CFU of probiotics orally for 30 days. Nos2 and Cd86 mRNA levels were determined as markers of M1 macrophages, and Cd163 and Arg1 as M2 markers, respectively, by qRT-PCR. Liver damage was determined by lipid peroxidation, leukocyte infiltration and myeloperoxidase activity. We evaluated a panoply of circulating chemokines, the hepatic ratio P-Akt/Akt, NF-kB and P-NF-kB protein levels. All 3 probiotic strains modulated macrophage polarization in liver and circulating levels of inflammation-related mediators. L. paracasei CNCM I-4034 increased the ratio P-Akt/Akt and NF-kB protein levels. B. breve CNCM I-4035, L. paracasei CNCM I-4034 and L. rhamnosus CNCM I-4036 decreased both pro-inflammatory macrophage gene expression and leukocyte infiltration in the liver.Keywords
Funding Information
- Hero Spain, S. A (3545)
- Junta de Andalucía (PI-0538-2017)
This publication has 39 references indexed in Scilit:
- Targeting CCL5 in inflammationExpert Opinion on Therapeutic Targets, 2013
- Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver AxisPLOS ONE, 2013
- Cell-Free Culture Supernatant of Bifidobacterium breve CNCM I-4035 Decreases Pro-Inflammatory Cytokines in Human Dendritic Cells Challenged with Salmonella typhi through TLR ActivationPLOS ONE, 2013
- Isolation, identification and characterisation of three novel probiotic strains (Lactobacillus paracaseiCNCM I-4034,Bifidobacterium breveCNCM I-4035 andLactobacillus rhamnosusCNCM I-4036) from the faeces of exclusively breast-fed infantsBritish Journal of Nutrition, 2013
- Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulationTherapeutic Advances in Gastroenterology, 2012
- Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian IndiansAtherosclerosis, 2012
- The role of junctional adhesion molecules in vascular inflammationNature Reviews Immunology, 2007
- The gut microbiota as an environmental factor that regulates fat storageProceedings of the National Academy of Sciences of the United States of America, 2004
- Myeloperoxidase as a biomarker of skin irritation and inflammationFood and Chemical Toxicology, 1994
- Inhibition of in vitro microsomal lipid peroxidation by isoflavonoidsBiochemical Pharmacology, 1985